Recall Register

Food, drugs, devices › Golden State Medical Supply Inc.

Drug recall: Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA,

FDA enforcement event 99732 · Class II · initiated 21 Aug 2026 · status Ongoing

DrugVoluntary: Firm initiated1 product recordCamarillo, CA

FDA enforcement event 99732 is a drug recall by Golden State Medical Supply Inc. of Camarillo, CA, initiated 21 Aug 2026 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 74% of the 234 drug enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Golden State Medical Supply Inc. has 32 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Golden State Medical Supply Inc., Camarillo, CA.

Reason for recall

"Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution"

Distribution

"US Nationwide."

Product records

Recall numberProductQuantityClassStatusReport date
D-0847-2026Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.6791 30-count bottlesClass IIOngoing9 Sep 2026

Context

74%of 2026 drug events are Class II234 events that year
1product record in this eventfirm median: 1
32events on this register for the firm

Other enforcement events for Golden State Medical Supply Inc.

InitiatedProduct (first record)TypeClassRecords
7 Aug 2026Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-DrugClass II1
29 May 2026GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban PhDrugClass II1
27 Apr 2026Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, IncoDrugClass III2
26 Nov 2025Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-1DrugClass II1
20 Oct 2025NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban PharmaceuDrugClass II1
5 Mar 2025PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-3DrugClass II1
13 May 2024Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottleDrugClass II1
14 Feb 2024Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: ADrugClass II1
12 Jan 2024Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPDrugClass II1
10 Nov 2023PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDC 60429-734-90; cDrugClass II3

All 32 events for Golden State Medical Supply Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.